urea derivatives
Recently Published Documents


TOTAL DOCUMENTS

691
(FIVE YEARS 131)

H-INDEX

38
(FIVE YEARS 7)

2022 ◽  
Author(s):  
Mahsa Toolabi ◽  
Fatemeh Safari ◽  
Adileh Ayati ◽  
Parnian Fathi ◽  
Setareh Moghimi ◽  
...  
Keyword(s):  

2022 ◽  
pp. 132318
Author(s):  
Muhammed GÖMEÇ ◽  
Fatih YULAK ◽  
Hayreddin GEZEGEN ◽  
Mustafa ÖZKARACA ◽  
Koray SAYIN ◽  
...  

2022 ◽  
Author(s):  
Jia-Nian Chen ◽  
Chu-Ting Chen ◽  
Yue-Zhen He ◽  
Tai-Sheng Qin ◽  
Li Cheng ◽  
...  

Correction for ‘Concise synthesis and biological activity evaluation of novel pyrazinyl–aryl urea derivatives against several cancer cell lines, which can especially induce T24 apoptotic and necroptotic cell death’ by Jia-Nian Chen et al., RSC Med. Chem., 2021, DOI: 10.1039/d1md00306b.


2021 ◽  
Author(s):  
Aniekan Owen ◽  
Annika Preiss ◽  
Angus McLuskie ◽  
Chang Gao ◽  
Gavin Peters ◽  
...  

Urea derivatives are prevalent intermediates in the synthesis of resin precursors, dyes, agrochemicals, and pharmaceutical drugs. Furthermore, polyureas are useful plastics with applications in coating, adhesive, and biomedical industries and have a current annual market of USD 885 million. However, the conventional methods for the synthesis of urea derivatives and polyureas involve toxic reagents such as (di)isocyanates, phosgene, CO, and azides. We present here the synthesis of (poly)ureas using much less toxic reagents - (di)amines, and methanol via a catalytic dehydrogenative coupling process. The reaction is catalyzed by a pincer complex of an earth-abundant metal, manganese, and liberates H2 gas, valuable by itself, as the only by-product making the overall process atom-economic, and sustainable. A broad variety of symmetrical, and unsymmetrical urea derivatives and polyureas have been synthesized in moderate to quantitative yields using this catalytic protocol. Mechanistic insights have also been provided using experiments and DFT computation suggesting that the reaction proceeds via an isocyanate intermediate.


Author(s):  
Poojita K ◽  
Fajeelath Fathima ◽  
Rajdeep Ray ◽  
Lalit Kumar ◽  
Ruchi Verma

Tuberculosis is one of the leading cause of increase in mortality rate in today’s health care scenario. Due to increase frequency of drug resistant TB it is prudent to find new targets and promising targets for anti-tubercular activity. MmpL3 (Mycobacterial Membrane Protein Large 3) is one of the most effective and promiscuous targets for development of new drug for anti-tubercular therapy due to its cross resistance inhibition property. In this study we have presented atom based 3D QSAR and finger print based 2D QSAR models to study different structural and functional groups of Adamantyl urea derivatives and their action in MmpL3 inhibitory activity which will provide us the insight for designing better and far more effective anti TB drugs.


Molecules ◽  
2021 ◽  
Vol 27 (1) ◽  
pp. 104
Author(s):  
Manish Kumar Mishra ◽  
Samiksha Kukal ◽  
Priyanka Rani Paul ◽  
Shivangi Bora ◽  
Anju Singh ◽  
...  

Valproic acid (VPA) is a well-established anticonvulsant drug discovered serendipitously and marketed for the treatment of epilepsy, migraine, bipolar disorder and neuropathic pain. Apart from this, VPA has potential therapeutic applications in other central nervous system (CNS) disorders and in various cancer types. Since the discovery of its anticonvulsant activity, substantial efforts have been made to develop structural analogues and derivatives in an attempt to increase potency and decrease adverse side effects, the most significant being teratogenicity and hepatotoxicity. Most of these compounds have shown reduced toxicity with improved potency. The simple structure of VPA offers a great advantage to its modification. This review briefly discusses the pharmacology and molecular targets of VPA. The article then elaborates on the structural modifications in VPA including amide-derivatives, acid and cyclic analogues, urea derivatives and pro-drugs, and compares their pharmacological profile with that of the parent molecule. The current challenges for the clinical use of these derivatives are also discussed. The review is expected to provide necessary knowledgebase for the further development of VPA-derived compounds.


Molecules ◽  
2021 ◽  
Vol 26 (23) ◽  
pp. 7179
Author(s):  
Ekaterina E. Khramtsova ◽  
Ekaterina A. Lystsova ◽  
Evgeniya V. Khokhlova ◽  
Maksim V. Dmitriev ◽  
Andrey N. Maslivets

The 3-hydroxy-1,5-dihydro-2H-pyrrol-2-one motif is a valuable scaffold in drug discovery. The replacement of the 3-oxy fragment in 3-hydroxy-1,5-dihydro-2H-pyrrol-2-ones-based compounds with a 3-amino one (3-amino analogs of 3-hydroxy-1,5-dihydro-2H-pyrrol-2-ones, 3-amino-1,5-dihydro-2H-pyrrol-2-ones) can play a crucial role in their biological effect. Thus, approaches to 3-amino-1,5-dihydro-2H-pyrrol-2-ones are of significant interest. We developed an approach to 5-spiro-substituted 3-amino-1,5-dihydro-2H-pyrrol-2-ones that could not be obtained using previously reported approaches (reactions of 3-hydroxy-1,5-dihydro-2H-pyrrol-2-ones with amines). The developed approach is based on the thermal decomposition of 1,3-disubstituted urea derivatives of 5-spiro-substituted 3-hydroxy-1,5-dihydro-2H-pyrrol-2-ones, which were prepared via their reaction with carbodiimides.


Sign in / Sign up

Export Citation Format

Share Document